Flaga, Reygine G.
HRN: 26-61-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/26/2025
02/09/2025
IV
600 Mg
Q8H
Open Fracture
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes